Navigation Links
Yale study identifies possible bacterial drivers of IBD
Date:8/28/2014

Yale University researchers have identified a handful of bacterial culprits that may drive inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis, using patients' own intestinal immune responses as a guide.

The findings are published Aug. 28 in the journal Cell.

Trillions of bacteria exist within the human intestinal microbiota, which plays a critical role in the development and progression of IBD. Yet it's thought that only a small number of bacterial species affect a person's susceptibility to IBD and its potential severity.

"A handful of bad bacteria are able to attain access to the immune system and get right at the gut," said Richard Flavell, the Sterling Professor of Immunobiology at the Yale School of Medicine. "If you look at the bacteria to which we have made an immune response, you can begin to find these bad actors."

Flavell's research team focused on antibody coatings on the surface of bacteria. In particular, Yale researchers looked at bacteria with high concentrations of an antibody coating called Immunoglobulin A (IgA).

"The coating is our body's attempt to neutralize the bacteria," Flavell said. "It binds to the bad bacteria. We only make these IgA responses to a limited number of organisms."

He and his team confirmed a correlation between high levels of IgA coating and inflammatory responses in the human intestine. To do this, the team collected "good" and "bad" bacteria from a small group of patients and transplanted them into mice. In healthy mice, there was no influence on intestinal inflammation; in mice with induced colitis, those with the suspected "bad" bacteria showed signs of excessive inflammation and other IBD symptoms.

Flavell warned that more research is necessary to learn how many bacterial species fall into the "bad" category and whether those populations are common to all IBD patients or are unique to each patient.

But the study's results indicate that anti-bacterial therapies for IBD are possible, Flavell said. Such anti-bacterial approaches might include highly specific antibiotics, vaccines, and probiotics.

"We believe an anti-bacterial strategy has a place in treating IBD," Flavell said.


'/>"/>

Contact: Jim Shelton
james.shelton@yale.edu
203-432-3881
Yale University
Source:Eurekalert  

Related biology news :

1. Study finds marine protected areas inadequate for protecting fish and ocean ecology
2. Breastfeeding study shows need for effective peer counseling programs
3. Study shows where on the planet new roads should and should not go
4. New study charts the global invasion of crop pests
5. Kessler Foundation researchers publish first study of brain activation in MS using fNIRS
6. More wolf spiders feasting on American toads due to invasive grass, UGA study shows
7. Stop and listen: Study shows how movement affects hearing
8. New study throws into question long-held belief about depression
9. Study calls into question link between prenatal antidepressant exposure and autism risk
10. Study: Earth can sustain more terrestrial plant growth than previously thought
11. WSU flu outbreak provides rare study material
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Yale study identifies possible bacterial drivers of IBD
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... ... April 20, 2017 , ... Husson University will ... community’s growing body of knowledge during its Eighth Annual Research and Scholarship ... adjacent Darling Atrium. During the event, undergraduates, graduate students, and faculty members from ...
(Date:4/20/2017)... /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" ... Liver Congress ("ILC") 2017 of the European Association for the ... on the positive effects of PBI-4050 on reduction of ... metabolic syndrome. ... Dr. Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic "This ...
(Date:4/20/2017)... ... April 20, 2017 , ... Parallel6™ , the ... worldwide, announced today that they were named one of the 2017 Top 10 ... latest developments in the pharmaceutical industry. , “We take pride in honoring Parallel6 as ...
(Date:4/20/2017)... Dutch philosopher Koert van Mensvoort - founder of ... of Technology in Eindhoven - has written a ,Letter to Humanity, ... humanity to avoid becoming a slave and victim to its own technology, but ... ... philosopher Koert van Mensvoort – founder of the Next Nature Network and Fellow ...
Breaking Biology Technology: